0,922  0,002  Antimutagenic
0,897  0,003  Aldehyde oxidase inhibitor
0,887  0,004  Caspase 9 stimulant
0,873  0,003  UGT1A6 substrate
0,844  0,003  UGT1A9 substrate
0,818  0,014  Apoptosis agonist
0,802  0,004  CTGF expression inhibitor
0,787  0,004  Free radical scavenger
0,769  0,004  CYP1A2 inhibitor
0,767  0,004  Amyloid beta aggregation inhibitor
0,766  0,011  Antineoplastic (lung cancer)
0,759  0,005  Antioxidant
0,756  0,003  UGT1A3 substrate
0,754  0,004  NOS2 expression inhibitor
0,753  0,014  Antineoplastic (breast cancer)
0,731  0,002  Cystathionine beta-synthase inhibitor
0,733  0,005  AR expression inhibitor
0,735  0,008  Aryl hydrocarbon receptor agonist
0,731  0,004  UGT1A1 substrate
0,728  0,005  Caspase 3 stimulant
0,722  0,006  12-Lipoxygenase inhibitor
0,721  0,011  15-Lipoxygenase inhibitor
0,720  0,013  Antineoplastic (colorectal cancer)
0,712  0,008  CYP1A2 substrate
0,713  0,013  Antineoplastic (colon cancer)
0,703  0,005  Histamine release inhibitor
0,705  0,013  TNF expression inhibitor
0,693  0,002  UGT2B15 substrate
0,699  0,010  Chemoprotective
0,684  0,005  Tubulin antagonist
0,672  0,004  GABA C receptor rho-3 antagonist
0,672  0,005  5 Hydroxytryptamine release inhibitor
0,671  0,005  Cardioprotectant
0,689  0,036  Alpha-glucosidase inhibitor
0,666  0,024  Transcription factor NF kappa B inhibitor
0,653  0,011  Chemopreventive
0,655  0,013  Prostate cancer treatment
0,650  0,009  Antineoplastic (cervical cancer)
0,640  0,008  Lipoxygenase inhibitor
0,625  0,004  Peroxidase inhibitor
0,626  0,006  Superoxide dismutase inhibitor
0,623  0,004  Breast cancer-resistant protein inhibitor
0,621  0,005  P-glycoprotein inhibitor
0,619  0,004  Amylase inhibitor
0,634  0,020  Antileukemic
0,615  0,003  NADPH oxidase inhibitor
0,583  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,586  0,013  Cytostatic
0,581  0,009  Antiamyloidogenic
0,581  0,014  Antipruritic, allergic
0,573  0,005  Monophenol monooxygenase inhibitor
0,572  0,008  UDP-glucuronosyltransferase substrate
0,571  0,016  Antineoplastic (melanoma)
0,564  0,010  Antiprotozoal (Leishmania)
0,564  0,015  Proliferative diseases treatment
0,552  0,013  Antineoplastic (non-small cell lung cancer)
0,543  0,006  Genotoxic
0,537  0,005  Topoisomerase II inhibitor
0,536  0,005  Acetylcholinesterase inhibitor
0,535  0,005  Melanin inhibitor
0,546  0,018  Radioprotector
0,533  0,009  Antineoplastic enhancer
0,529  0,008  Antihypoxic
0,532  0,017  Ulceration
0,519  0,006  Skin whitener
0,519  0,008  UGT2B4 substrate
0,533  0,023  Antihypercholesterolemic
0,525  0,018  CYP2C19 inhibitor
0,510  0,005  Antineoplastic (gastric cancer)
0,535  0,030  CYP2C9 substrate
0,510  0,006  Antineoplastic (squamous cell carcinoma)
0,510  0,009  UGT1A4 substrate
0,512  0,011  Antimitotic
0,514  0,014  Vasodilator, coronary
0,514  0,017  Antineoplastic (glioma)
0,497  0,004  Alpha tubulin antagonist
0,502  0,011  Antihypertriglyceridemic
0,494  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,498  0,009  Antineoplastic (carcinoma)
0,502  0,014  Tumour necrosis factor alpha release inhibitor
0,510  0,026  CYP2C19 substrate
0,545  0,070  Antiinflammatory
0,489  0,015  DNA damaging
0,486  0,012  RNA-directed DNA polymerase inhibitor
0,498  0,027  Antineoplastic (ovarian cancer)
0,510  0,040  Prostaglandin dehydrogenase inhibitor
0,471  0,006  Lipid peroxidase inhibitor
0,470  0,008  MAO inhibitor
0,483  0,023  Apoptosis antagonist
0,466  0,006  Sulfotransferase substrate
0,467  0,008  Antiseptic
0,476  0,023  NOS3 expression inhibitor
0,475  0,026  FMO1 substrate
0,468  0,018  Nitric oxide antagonist
0,456  0,007  Cholinergic
0,457  0,013  Pyruvate kinase inhibitor
0,486  0,043  CYP3A4 substrate
0,472  0,031  CYP2C9 inhibitor
0,443  0,004  Topoisomerase II alpha inhibitor
0,455  0,020  Hypoglycemic
0,437  0,003  GABA C receptor rho-2 antagonist
0,438  0,004  SULT1A3 substrate
0,447  0,015  Antineoplastic (osteosarcoma)
0,438  0,007  MAO A inhibitor
0,435  0,005  CYP2B6 inhibitor
0,461  0,034  5 Hydroxytryptamine release stimulant
0,434  0,009  5 Hydroxytryptamine uptake stimulant
0,434  0,011  Dual specificity phosphatase inhibitor
0,439  0,017  Vascular (periferal) disease treatment
0,439  0,022  Antineoplastic (glioblastoma multiforme)
0,427  0,011  Hepatoprotectant
0,420  0,004  Xanthine oxidase inhibitor
0,444  0,029  Antineoplastic (brain cancer)
0,427  0,013  Antineoplastic (sarcoma)
0,424  0,011  Dual specificity phosphatase 3 inhibitor
0,456  0,047  Calcium channel L-type activator
0,427  0,019  Vasodilator
0,412  0,004  Beta tubulin antagonist
0,432  0,027  Antineoplastic (multiple myeloma)
0,415  0,010  GST M1-1 substrate
0,409  0,006  Tumour necrosis factor antagonist
0,429  0,027  Mutagenic
0,429  0,032  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,427  0,032  Antineoplastic (pancreatic cancer)
0,422  0,036  Spasmolytic
0,411  0,025  Radiosensitizer
0,389  0,004  Carbonic anhydrase VI inhibitor
0,405  0,026  Antipyretic
0,382  0,004  Nitric-oxide synthase stimulant
0,380  0,004  Carbonic anhydrase XIII inhibitor
0,380  0,005  Interleukin 4 antagonist
0,398  0,024  Antineoplastic (renal cancer)
0,394  0,020  Antineoplastic (small cell lung cancer)
0,411  0,040  Hepatic disorders treatment
0,381  0,011  VCAM1 expression inhibitor
0,386  0,017  Antineoplastic (bladder cancer)
0,399  0,030  Cardiovascular analeptic
0,377  0,011  Pneumotoxic
0,370  0,005  Antihemorrhagic
0,396  0,032  Carcinogenic
0,368  0,007  Butyrylcholinesterase inhibitor
0,370  0,017  Non-steroidal antiinflammatory agent
0,353  0,004  LDLR expression enhancer
0,354  0,006  Gout treatment
0,351  0,004  VEGF expression inhibitor
0,391  0,045  CYP2D6 substrate
0,361  0,016  UGT2B7 substrate
0,425  0,081  Alzheimer's disease treatment
0,368  0,025  Antineoplastic (lymphocytic leukemia)
0,353  0,012  Protein kinase stimulant
0,345  0,004  Creatine kinase inhibitor
0,345  0,004  Gastritis treatment
0,344  0,004  Carbonic anhydrase III inhibitor
0,338  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,343  0,010  MAO B inhibitor
0,334  0,009  Chelator
0,326  0,004  Multidrug resistance-associated protein 1 inhibitor
0,399  0,077  Antibacterial
0,354  0,035  Antidiabetic symptomatic
0,375  0,057  Bone diseases treatment
0,324  0,009  5-Lipoxygenase inhibitor
0,351  0,037  Cardiodepressant
0,323  0,009  Alkaline phosphatase inhibitor
0,322  0,008  Carcinogenic, group 1
0,423  0,110  DNA polymerase beta inhibitor
0,347  0,035  Antineoplastic (liver cancer)
0,314  0,004  Aldose reductase inhibitor
0,312  0,004  Antihelmintic (Trematoda)
0,312  0,005  SULT1A1 substrate
0,380  0,077  Antiprotozoal
0,325  0,023  Antihypotensive
0,350  0,050  Antiosteoporotic
0,307  0,007  Mediator release inhibitor
0,342  0,042  Antiprotozoal (Trypanosoma)
0,356  0,059  ICAM1 expression inhibitor
0,323  0,027  Platelet adhesion inhibitor
0,340  0,045  Cytotoxic
0,305  0,010  Topoisomerase I inhibitor
0,310  0,016  NOS3 expression enhancer
0,368  0,079  GST A substrate
0,300  0,013  Glutathione S-transferase substrate
0,397  0,117  DNA directed DNA polymerase inhibitor
0,291  0,013  Aldehyde dehydrogenase inhibitor
0,303  0,025  DNA methyltransferase I inhibitor
0,330  0,054  Sodium/bile acid cotransporter inhibitor
0,277  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,301  0,030  Antiviral (Influenza)
0,277  0,010  Carbonic anhydrase XV inhibitor
0,331  0,064  Calcium channel activator
0,326  0,061  Analeptic
0,315  0,052  Sensitization
0,284  0,021  Amyloid beta precursor protein antagonist
0,312  0,049  Transcription factor STAT inhibitor
0,270  0,008  Histidine decarboxylase inhibitor
0,271  0,009  UGT2B10 substrate
0,286  0,026  Mcl-1 antagonist
0,266  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,265  0,005  Antineoplastic (uterine cancer)
0,295  0,044  Antiparasitic
0,267  0,016  UGT2B9 substrate
0,285  0,035  Antihelmintic
0,316  0,068  Respiratory analeptic
0,266  0,018  Succinate dehydrogenase inhibitor
0,273  0,025  Protein-tyrosine phosphatase inhibitor
0,292  0,045  Cyclic AMP phosphodiesterase inhibitor
0,253  0,007  Uric acid excretion stimulant
0,326  0,084  Antiprotozoal (Plasmodium)
0,244  0,004  GABA C receptor rho-1 antagonist
0,292  0,052  Angiogenesis stimulant
0,260  0,021  Antidote
0,274  0,037  DNA methylase inhibitor
0,241  0,005  Macrophage migration inhibitory factor inhibitor
0,244  0,009  Beta glucuronidase inhibitor
0,279  0,045  Tyrosine 3 hydroxylase inhibitor
0,240  0,008  CF transmembrane conductance regulator agonist
0,251  0,020  Antineoplastic (bone cancer)
0,307  0,077  Antifungal
0,241  0,014  Mannose-6-phosphate isomerase inhibitor
0,244  0,019  Antiprotozoal (Coccidial)
0,236  0,012  Toll-Like receptor 2 antagonist
0,250  0,026  Cyclooxygenase inhibitor
0,238  0,016  Phobic disorders treatment
0,244  0,022  Cyclooxygenase 1 inhibitor
0,226  0,006  DNA repair enzyme inhibitor
0,245  0,026  Antiviral (Influenza A)
0,226  0,012  Choleretic
0,279  0,068  Teratogen
0,293  0,083  CYP3A4 inhibitor
0,213  0,004  Xanthine dehydrogenase inhibitor
0,298  0,089  Antithrombotic
0,215  0,008  Aromatase inhibitor
0,215  0,010  GABA C receptor antagonist
0,212  0,007  Electron transport complex I inhibitor
0,222  0,021  Alkylator
0,212  0,013  Telomerase inhibitor
0,209  0,012  Estrogen antagonist
0,206  0,009  Estrogen receptor beta antagonist
0,223  0,027  M18 aspartyl aminopeptidase inhibitor
0,221  0,025  Antifungal enhancer
0,200  0,007  DOPA decarboxylase inhibitor
0,340  0,147  Antineoplastic (solid tumors)
0,222  0,030  Bone formation stimulant
0,270  0,079  Insulysin inhibitor
0,249  0,060  Antiulcerative
0,191  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,203  0,017  Cyclooxygenase 3 inhibitor
0,210  0,025  Antihyperlipoproteinemic
0,233  0,049  Neurotrophic factor enhancer
0,210  0,026  Protein-tyrosine phosphatase 1B inhibitor
0,274  0,090  Streptokinase A inhibitor
0,197  0,016  UGT2B1 substrate
0,204  0,026  Cholesterol synthesis inhibitor
0,206  0,029  Cyclooxygenase 2 inhibitor
0,181  0,007  Myeloperoxidase inhibitor
0,198  0,025  Antitussive
0,280  0,108  Vasodilator, peripheral
0,185  0,013  Protein kinase C zeta inhibitor
0,202  0,031  Arachidonic acid antagonist
0,179  0,009  SULT1E1 substrate
0,247  0,077  5 Hydroxytryptamine 1E antagonist
0,184  0,014  Papain-like protease (SARS coronavirus) inhibitor
0,178  0,009  Cyclin B3 inhibitor
0,244  0,074  Embryotoxic
0,256  0,087  Antituberculosic
0,202  0,036  Antirickettsial
0,249  0,083  Transcription factor STAT3 inhibitor
0,177  0,013  Heat shock protein 70 antagonist
0,262  0,100  Antimycobacterial
0,177  0,015  Sphingomyelinase inhibitor
0,170  0,009  Antifungal (Pneumocystis)
0,175  0,014  Urease inhibitor
0,235  0,074  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,196  0,038  Insulin secretagoues
0,168  0,012  Keratolytic
0,194  0,039  Carcinogenic, group 3
0,180  0,025  Expectorant
0,175  0,021  Mucolytic
0,156  0,005  D-Ala-D-Ala ligase inhibitor
0,155  0,005  Topoisomerase II beta inhibitor
0,179  0,029  Antibacterial (Helicobacter pylori)
0,170  0,021  Photosensitizer
0,225  0,077  Antineoplastic (lymphoma)
0,203  0,055  Antiviral (Ebola)
0,207  0,060  Histone acetyltransferase inhibitor
0,192  0,045  ATPase inhibitor
0,177  0,030  GST P1-1 substrate
0,185  0,039  Hemostatic
0,210  0,065  Abortion inducer
0,165  0,020  AMP-activated protein kinase stimulant
0,164  0,021  Antiviral (Influenza B)
0,176  0,033  DNA intercalator
0,155  0,013  UGT2B11 substrate
0,206  0,066  I kappa B kinase epsilon inhibitor
0,153  0,014  Carbonic anhydrase V inhibitor
0,167  0,028  Coagulant
0,145  0,006  Carbonic anhydrase VII inhibitor
0,256  0,118  Angiogenesis inhibitor
0,158  0,020  Androgen antagonist
0,149  0,012  Estrogen receptor alpha antagonist
0,146  0,010  Thioredoxin reductase inhibitor
0,169  0,033  Protein kinase (CK2) alpha inhibitor
0,147  0,012  Postmenopausal disorders treatment
0,182  0,048  Heat shock protein 90 antagonist
0,153  0,019  Phosphodiesterase 4D inhibitor
0,148  0,017  Antiviral (SARS coronavirus)
0,148  0,017  Antiviral (Coronavirus)
0,154  0,024  Dementia treatment
0,201  0,072  Insulin sensitizer
0,179  0,051  Neurotensin receptor agonist
0,146  0,018  Thioredoxin inhibitor
0,139  0,013  Carbonic anhydrase VA inhibitor
0,149  0,023  Vascular dementia treatment
0,136  0,011  HIV-1 integrase inhibitor
0,159  0,035  Carcinogenic, group 2B
0,213  0,090  Antiviral (West Nile virus)
0,175  0,053  Interferon gamma antagonist
0,152  0,031  Antiviral (Papilloma)
0,247  0,127  Cholesterol antagonist
0,132  0,013  Histone deacetylase stimulant
0,132  0,013  Histone deacetylase SIRT1 stimulant
0,128  0,010  Neuraminidase (influenza) inhibitor
0,153  0,036  Microtubule formation inhibitor
0,142  0,025  Carcinogenic, group 2A
0,209  0,094  Dyrk kinase inhibitor
0,133  0,018  Ornithine decarboxylase inhibitor
0,158  0,043  Antiprotozoal (Trichomonas)
0,130  0,018  Interleukin 5 antagonist
0,171  0,060  Acaricide
0,157  0,046  DNA polymerase I inhibitor
0,172  0,062  Antiviral (Herpes)
0,117  0,009  Estradiol 17 beta-dehydrogenase inhibitor
0,122  0,014  Granulocyte macrophage colony stimulating factor agonist
0,149  0,041  Beta amyloid protein antagonist
0,115  0,007  Fatty acid synthase inhibitor
0,181  0,074  Antipruritic, non-allergic
0,126  0,019  Glutamate decarboxylase inhibitor
0,133  0,027  Alcohol dehydrogenase inhibitor
0,110  0,005  Transcription factor RelA inhibitor
0,252  0,146  Immunosuppressant
0,123  0,018  CDC25A inhibitor
0,119  0,014  Estrogen agonist
0,121  0,017  mTOR complex 2 inhibitor
0,159  0,056  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,173  0,071  3C-like protease (Human coronavirus) inhibitor
0,108  0,007  Glutamate (mGluR7) antagonist
0,154  0,056  Adenylate cyclase stimulant
0,169  0,071  Heat shock protein 90 alpha antagonist
0,187  0,091  Interleukin antagonist
0,130  0,034  Antiprotozoal (Toxoplasma)
0,103  0,008  Potassium channel Kv1.3 blocker
0,278  0,183  Cyclophilin D inhibitor
0,278  0,183  Antidiabetic
0,135  0,040  Protein kinase (CK2) inhibitor
0,109  0,014  Antidote, heavy metal
0,131  0,036  Antineoplastic antibiotic
0,146  0,052  Ca2+-transporting ATPase inhibitor
0,099  0,005  GABA B receptor antagonist
0,097  0,004  Ryanodine receptor antagonist
0,113  0,021  Lipase inhibitor
0,165  0,076  Aldehyde oxidase substrate
0,159  0,069  Hexokinase inhibitor
0,103  0,014  Neuraminidase inhibitor
0,098  0,011  Carbonic anhydrase XIV inhibitor
0,126  0,040  Acetylcholine release stimulant
0,125  0,039  Chronic obstructive bronchitis treatment
0,118  0,034  Phosphodiesterase IV inhibitor
0,120  0,035  Arylamine N-Acetyltransferase substrate
0,101  0,016  Maillard reaction inhibitor
0,119  0,035  Calcium antagonist
0,100  0,016  Carbonic anhydrase VB inhibitor
0,088  0,004  Nucleoside transporters inhibitor
0,170  0,087  Antiviral (Hepatitis)
0,090  0,009  Postcoital contraceptive
0,088  0,008  DNA-dependent protein kinase inhibitor
0,200  0,120  Immunostimulant
0,218  0,139  FMO3 substrate
0,082  0,005  Neuraminidase (Influenza A) inhibitor
0,093  0,017  Aryl hydrocarbon receptor antagonist
0,118  0,046  Bronchodilator
0,113  0,042  Antifungal (Aspergillus)
0,098  0,028  Estrogen-related receptor beta agonist
0,154  0,085  Muscular dystrophy treatment
0,187  0,120  Myocardial infarction treatment
0,137  0,071  Psychosexual dysfunction treatment
0,101  0,036  Glutathione S-transferase inhibitor
0,114  0,050  Toll-Like receptor 4 antagonist
0,125  0,062  Contraceptive female
0,105  0,042  Actinic keratosis treatment
0,084  0,021  Protease activated receptor antagonist
0,082  0,022  Beta 3 adrenoreceptor antagonist
0,102  0,042  NADH dehydrogenase inhibitor
0,115  0,056  Antihelmintic (Fasciola)
0,107  0,048  HIV-1 integrase (Overall Integration) inhibitor
0,211  0,153  Thyroid hormone antagonist
0,211  0,153  Antiallergic
0,148  0,092  Interleukin 6 antagonist
0,071  0,015  Glucose-6-phosphate translocase inhibitor
0,077  0,021  Cyclin D1 inhibitor
0,100  0,045  Antidote, mercury
0,092  0,039  Na+ K+ transporting ATPase inhibitor
0,117  0,065  Transcription factor STAT6 inhibitor
0,096  0,044  Antiviral (Hepatitis A)
0,068  0,016  CD45 antagonist
0,152  0,103  Sedative
0,068  0,019  DNA helicase inhibitor
0,201  0,153  Thyroid hormone beta antagonist
0,080  0,033  Anticholelithogenic
0,145  0,097  Antiviral (Hepatitis C)
0,062  0,015  Cholesterol esterase inhibitor
0,059  0,012  Dopamine D5 agonist
0,073  0,027  Alcohol oxidase inhibitor
0,264  0,218  MAP kinase 1 inhibitor
0,082  0,037  Antitreponemal
0,050  0,005  Estrogen-related receptor beta antagonist
0,079  0,034  Dopamine D1 antagonist
0,078  0,033  Leukotriene antagonist
0,150  0,107  Phospholipase C inhibitor
0,140  0,097  Antihelmintic (Nematodes)
0,093  0,051  ATPase (Vacuolar H+) inhibitor
0,135  0,093  Phospholipase A2 inhibitor
0,123  0,081  Vanilloid 1 agonist
0,079  0,038  Leukotriene synthesis inhibitor
0,113  0,072  Proteasome inhibitor
0,189  0,148  Flavin-containing monooxygenase substrate
0,118  0,079  Alpha-N-acetylglucosaminidase inhibitor
0,100  0,061  UDP-glucose 4-epimerase inhibitor
0,050  0,011  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,058  0,020  Factor III inhibitor
0,110  0,072  TRPA1 agonist
0,054  0,016  Estrogen receptor alpha agonist
0,055  0,018  Estrogen receptor beta agonist
0,062  0,025  Leukotriene C antagonist
0,096  0,060  Interleukin 12 antagonist
0,047  0,011  Vanilloid 3 antagonist
0,042  0,008  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,072  0,039  SULT2A1 substrate
0,067  0,034  Phosphodiesterase 1C inhibitor
0,062  0,030  Cyclin B2 inhibitor
0,120  0,088  Interleukin 1 antagonist
0,070  0,038  Beta adrenoreceptor antagonist
0,136  0,105  Uterine stimulant
0,201  0,172  Thioredoxin glutathione reductase inhibitor
0,092  0,063  ABCA1 expression enhancer
0,121  0,092  Antiparkinsonian, tremor relieving
0,058  0,030  Leukotriene B4 antagonist
0,065  0,037  Cyclin B1 inhibitor
0,089  0,063  Glutamate release inhibitor
0,060  0,034  Protein kinase C eta inhibitor
0,148  0,123  MAP kinase kinase 2 inhibitor
0,228  0,203  Transcription factor inhibitor
0,038  0,014  ATP citrate lysase inhibitor
0,228  0,204  Antiparkinsonian
0,040  0,016  Melatonin 2 agonist
0,039  0,016  Tubulin agonist
0,127  0,104  Eye irritation, high
0,094  0,072  Alpha 2c adrenoreceptor antagonist
0,121  0,099  Cytidine deaminase inhibitor
0,108  0,086  Retinopathy treatment
0,094  0,072  Anabolic
0,062  0,041  Purinergic P2X1 antagonist
0,081  0,060  Inducible nitric-oxide synthase inhibitor
0,074  0,053  Phosphodiesterase VI inhibitor
0,143  0,122  Anesthetic general
0,056  0,036  GABA receptor antagonist
0,098  0,080  GST T1-1 substrate
0,062  0,043  Antimycoplasmal
0,039  0,022  Inosine monophosphate dehydrogenase inhibitor
0,130  0,113  Aldose reductase substrate
0,073  0,056  SULT1A2 substrate
0,072  0,056  CYP2A6 inhibitor
0,035  0,019  Catechol O-methyltransferase inhibitor
0,163  0,147  ErbB-1 antagonist
0,035  0,020  Estrogen-related receptor alpha antagonist
0,084  0,069  Phosphodiesterase I inhibitor
0,039  0,026  Leukotriene C4 antagonist
0,038  0,024  Arginase inhibitor
0,112  0,098  Cytokine production inhibitor
0,036  0,023  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,025  0,012  Monocarboxylic acid transporter inhibitor
0,025  0,012  Monocarboxylic acid transporter 1 inhibitor
0,061  0,050  CDC25B inhibitor
0,072  0,062  GABA B receptor agonist
0,173  0,163  DNA synthesis inhibitor
0,138  0,128  Antiarrhythmic
0,052  0,042  Cyclin B inhibitor
0,064  0,055  Glutamate (mGluR6) antagonist
0,048  0,039  Carbonic anhydrase XII inhibitor
0,155  0,146  Antiviral (HIV)
0,064  0,055  CDK1/cyclin B1 inhibitor
0,021  0,012  Inosine monophosphate dehydrogenase 2 inhibitor
0,040  0,033  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,066  0,059  Cathepsin G inhibitor
0,054  0,048  Pregnane X receptor antagonist
0,061  0,055  Calcium channel P-type blocker
0,105  0,099  Antiprotozoal (Amoeba)
0,058  0,052  Nitric oxide donor
0,019  0,013  Antibiotic Anthracycline-like
0,048  0,043  Anesthetic inhalation
0,083  0,081  Antiviral (Rhinovirus)
0,053  0,052  Androgen agonist
0,086  0,085  GABA C receptor agonist
0,104  0,103  Retinoprotector
0,080  0,080  Paget's disease treatment
0,055  0,055  Enoyl-[acyl-carrier-protein] reductase inhibitor

